Sana Biotechnology, Inc. (SANA) Misses Q1 EPS by 19c
Tweet
Share
E-mailGet Alerts SANA Hot Sheet
Join SI Premium – FREE
Sana Biotechnology, Inc. (NASDAQ: SANA) reported Q1 EPS of ($0.49), $0.19 worse than the analyst estimate of ($0.30).
For earnings history and earnings-related data on Sana Biotechnology, Inc. (SANA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Synopsys upgraded at Piper Sandler on Intel foundry momentum, Apple opportunity
- Cerebras Systems posts 94% revenue jump, announces OpenAI deal
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
